Boxes of Wegovy made by Novo Nordisk at a pharmacy in London on March 8, 2024. Hollie Adams/Reuters
Multiple lots of weight-loss medication Wegovy were recalled by pharmaceutical giant Novo Nordisk because hair was found in a prefilled syringe, according to two notices published by the Food and Drug Administration (FDA) this week.
The recall entails lots of four Wegovy, or semaglutide, single-dose prefilled pens in 0.5 mg/0.5 mL doses, according to an FDA notice issued on Dec. 31. The other notice, published on the same day, said that four Wegovy single-dose prefilled pens at 1 mg/0.5 mL doses are also under recall.We had a problem loading this article. Please enable javascript or use a different browser. If the issue persists, please visit our help center.
Read Full Article: https://www.theepochtimes.com/health/wegovy-lots-recalled-after-hair-is-detected-in-a-prefilled-syringe-5965386/?utm_source=partner&utm_campaign=whatfinger
